STOCK TITAN

MOLINA HEALTHCARE, INC. (MOH) SEC Filings, May-Jul 2026

MOH NYSE

Welcome to our dedicated page for MOLINA HEALTHCARE SEC filings (Ticker: MOH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Molina Healthcare, Inc. filings document the regulatory record for a managed healthcare company serving Medicaid, Medicare and state insurance marketplace programs. Its 8-K reports disclose operating results, premium revenue and earnings guidance, Regulation FD investor presentations, material agreements, direct financial obligations, impairment charges and senior unsecured note financing.

The company's proxy and governance filings cover annual meeting proposals, director and executive compensation matters, equity incentive plan authorization and amendments to charter or bylaw provisions such as stockholder special-meeting rights. The filing record also describes capital-structure terms, credit agreement covenants, risk-factor references and shareholder voting outcomes.

Rhea-AI Summary

ORLANDO STEVEN J reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Steven J. Orlando, through the Orlando Family Trust, received a grant of 237 shares of common stock on July 1, 2026 under the company’s 2025 Equity Incentive Plan. The grant represents a quarterly equity award valued at $55,000, based on the $232.55 closing share price, as part of a $220,000 annual director equity package. Following this award, the trust holds 17,967 shares, and an additional 1,500 shares are held indirectly through Orlando’s 401(k) plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Lockhart Stephen H reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Stephen H. Lockhart received a stock award rather than making an open-market purchase. He was granted 237 shares of common stock on July 1, 2026 at a reference price of $232.55 per share under the company’s 2025 Equity Incentive Plan.

This grant represents one quarterly installment of an annual equity award valued at $220,000 for each director, with $55,000 granted on the first day of each quarter based on the closing share price that day. After this award, Lockhart directly holds 4,384 Molina Healthcare shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

GROHOWSKI LEO P reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Leo P. Grohowski received a grant of 237 shares of Common Stock on July 1, 2026 as compensation for his board service. The shares were issued under Molina Healthcare’s 2025 Equity Incentive Plan at a price of $232.55 per share, based on the closing market price that day.

This quarterly equity award represents one quarter of an annual director equity value of $220,000, with $55,000 granted each quarter. Following this grant, Grohowski directly holds 1,542 shares of Molina Healthcare common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Francis S. Soistman Jr. received a grant of 237 shares of common stock on July 1, 2026. The shares were awarded under the company’s 2025 Equity Incentive Plan as part of his director compensation, based on the stock’s closing price of $232.55.

The filing notes that each director’s annual equity award is valued at $220,000, with $55,000 granted on the first day of each quarter. Following this grant, Soistman directly holds 907 shares of Molina Healthcare common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

BRASIER BARBARA L reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare, Inc. director Barbara L. Brasier received a grant of 237 shares of common stock as part of her director compensation. The shares were granted under the company’s 2025 Equity Incentive Plan, based on the July 1, 2026 closing price of $232.55 per share.

The award represents one quarterly installment of a $220,000 annual equity award for each director, with this quarter’s portion set at $55,000. Following this grant, Brasier directly holds 5,818 shares of Molina Healthcare common stock, reflecting routine, compensation-related equity ownership rather than an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Molina Healthcare Chief Operating Officer James Woys acquired 144 shares of common stock under the company’s 2019 Employee Stock Purchase Plan. The shares were purchased at $147.51 per share, equal to 85% of the lower closing price of $173.54 during the offering period. Following this ESPP acquisition, Woys directly holds 90,178 shares of Molina Healthcare common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Molina Healthcare, Inc. Chief Legal Officer Jeff D. Barlow increased his direct stake through the company’s employee stock purchase plan. He acquired 138 shares of common stock on June 30, 2026 at a plan price of $147.51 per share, bringing his direct holdings to 67,313 shares.

The shares were bought under Molina’s 2019 Employee Stock Purchase Plan, which sets the purchase price at 85% of the lower closing price on January 1, 2026 or June 30, 2026, using a reference price of $173.54. Footnotes also show that a portion of his broader equity awards will vest in tranches from March 2027 through March 2029.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Molina Healthcare EVP Debra Bacon reported routine share transactions tied to compensation and an employee plan. She acquired 23 shares of common stock on June 30, 2026 under the company’s 2019 Employee Stock Purchase Plan, with a purchase price equal to 85% of the $173.54 closing price on January 1, 2026. On July 1, 2026, 183 shares were surrendered at $232.55 per share to cover withholding taxes on the vesting of 529 shares. After these transactions, she directly holds 21,636 Molina Healthcare shares, and remaining restricted shares are scheduled to vest in March 2027, March 2028, and March 2029.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Molina Healthcare, Inc. announced that the Illinois Department of Healthcare and Family Services intends to award a HealthChoice Illinois Medicaid Managed Care program contract to its subsidiary, Molina Healthcare of Illinois. The planned go-live date is January 1, 2027.

The contract is expected to run for four-and-a-half years, with an option for the state to extend it by up to an additional five-and-a-half years. Molina Healthcare of Illinois will be one of six health plans serving roughly 3.1 million total Medicaid beneficiaries in Illinois.

The announcement is forward-looking and subject to risks, including possible protests or legal actions, delays to the start date, or a shorter contract term than anticipated.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.37%
Tags
current report
Rhea-AI Summary

Molina Healthcare Chief Accounting Officer Maurice Hebert sold 600 shares of common stock in an open-market transaction at $191.55 per share. After the sale, he directly holds 12,815 shares. Footnotes indicate additional restricted shares are scheduled to vest in 2027, 2028, and 2029, with remaining awards already vested.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many MOLINA HEALTHCARE (MOH) SEC filings are available on StockTitan?

StockTitan tracks 103 SEC filings for MOLINA HEALTHCARE (MOH), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for MOLINA HEALTHCARE (MOH)?

The most recent SEC filing for MOLINA HEALTHCARE (MOH) was filed on July 2, 2026.